Morgan Stanley’s aTyr Pharma ATYR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.32M Sell
259,966
-2,713
-1% -$13.8K ﹤0.01% 4965
2025
Q1
$793K Buy
262,679
+221,466
+537% +$669K ﹤0.01% 5114
2024
Q4
$149K Buy
41,213
+41,212
+4,121,200% +$149K ﹤0.01% 5890
2024
Q3
$2 Hold
1
﹤0.01% 7915
2024
Q2
$2 Sell
1
-19,717
-100% -$39.4K ﹤0.01% 7834
2024
Q1
$38.5K Sell
19,718
-12,128
-38% -$23.7K ﹤0.01% 6311
2023
Q4
$44.9K Buy
31,846
+29,442
+1,225% +$41.5K ﹤0.01% 6421
2023
Q3
$3.8K Sell
2,404
-51
-2% -$81 ﹤0.01% 6978
2023
Q2
$5.3K Buy
2,455
+171
+7% +$369 ﹤0.01% 6974
2023
Q1
$4.8K Buy
+2,284
New +$4.8K ﹤0.01% 7059
2022
Q2
Sell
-72
Closed 8014
2022
Q1
$0 Sell
72
-20,393
-100% ﹤0.01% 8148
2021
Q4
$153K Buy
+20,465
New +$153K ﹤0.01% 6205
2020
Q4
Sell
-1,311
Closed -$4K 7130
2020
Q3
$4K Sell
1,311
-2,433
-65% -$7.42K ﹤0.01% 6486
2020
Q2
$17K Buy
+3,744
New +$17K ﹤0.01% 6047
2019
Q2
Sell
-244
Closed -$2K 6766
2019
Q1
$2K Sell
244
-33
-12% -$270 ﹤0.01% 6476
2018
Q4
$2K Hold
277
﹤0.01% 6444
2018
Q3
$3K Sell
277
-1,009
-78% -$10.9K ﹤0.01% 6527
2018
Q2
$16K Sell
1,286
-7
-0.5% -$87 ﹤0.01% 6204
2018
Q1
$48K Sell
1,293
-625
-33% -$23.2K ﹤0.01% 5894
2017
Q4
$94K Sell
1,918
-198
-9% -$9.7K ﹤0.01% 5653
2017
Q3
$150K Sell
2,116
-12
-0.6% -$851 ﹤0.01% 5462
2017
Q2
$102K Buy
2,128
+320
+18% +$15.3K ﹤0.01% 5629
2017
Q1
$89K Buy
1,808
+1,002
+124% +$49.3K ﹤0.01% 5643
2016
Q4
$24K Buy
806
+615
+322% +$18.3K ﹤0.01% 5956
2016
Q3
$8K Sell
191
-155
-45% -$6.49K ﹤0.01% 6156
2016
Q2
$14K Buy
346
+147
+74% +$5.95K ﹤0.01% 5966
2016
Q1
$11K Sell
199
-138
-41% -$7.63K ﹤0.01% 6113
2015
Q4
$47K Buy
337
+187
+125% +$26.1K ﹤0.01% 5741
2015
Q3
$21K Sell
150
-5
-3% -$700 ﹤0.01% 6039
2015
Q2
$40K Buy
+155
New +$40K ﹤0.01% 5935